Discover 1,112 paid clinical trials in Hartford, Connecticut. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,112
A First in Human Study of CMND-100 in Healthy and Alcohol Use Disorder (AUD) Subjects
for
Alcohol Use Disorder
Location: New Haven CT, Baltimore MD
Sponsor: Clearmind Medicine Inc.
Sex: All
Age: 18 - 60
Code: NCT05913752
Phase 1, Phase 2, Recruiting
A Study Exploring Changes in a Variety of Biomarkers Following Dosing With MT1988 in Participants at Clinical High Risk for Psychosis
for
Clinical High Risk for Psychosis (CHR)
Location: New Haven CT, Glen Oaks NY, Boston MA, New York NY,
Location: New Haven CT, Lake Success NY, New York NY, Fairfax VA,
Sponsor: Neomorph, Inc
Sex: All
Age: 18+
Code: NCT07300241
Phase 1, Recruiting
Transcranial Magnetic Stimulation (TMS) Study for Adults With Autism Spectrum Disorder (ASD)
for
Autism Spectrum Disorder
Location: New Haven CT
Sponsor: Yale University
Sex: All
Age: 18 - 40
Code: NCT04936009
Recruiting
Efficacy of Valbenazine for the Treatment of Trichotillomania in Adults
for
Trichotillomania (Hair-Pulling Disorder)
Location: New Haven CT
Sponsor: Yale University
Sex: All
Age: 18 - 65
Code: NCT05207085
Phase 2, Recruiting
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
for
Myelodysplastic Syndromes
Location: New Haven CT, Westbury NY, Columbia MD, Toronto, London,
Sponsor: Takeda
Sex: All
Age: 18+
Code: NCT06499285
Phase 3, Recruiting
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
for
Epithelial Ovarian Cancer, Primary Peritoneal,
Location: New Haven CT, Boston MA, New Brunswick NJ,
Sponsor: TORL Biotherapeutics, LLC
Sex: Female
Age: 18+
Code: NCT06690775
Phase 2, Recruiting
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML